On 2025-05-07, Mirum Pharmaceuticals, Inc. (MIRM) announced earnings per share of $-0.30 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.39.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-0.32 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-07 | 2025-03-31 | $-0.39 | $-0.30 |
| 2025-02-26 | 2024-12-31 | $-0.27 | $-0.49 |
| 2024-11-12 | 2024-09-30 | $-0.45 | $-0.30 |
| 2024-08-07 | 2024-06-30 | $-0.48 | $-0.52 |
| 2024-05-08 | 2024-03-31 | $-0.40 | $-0.54 |
| 2024-02-28 | 2023-12-31 | $-0.34 | $-0.66 |
| 2023-11-02 | 2023-09-30 | $-0.64 | $-0.57 |
| 2023-08-03 | 2023-06-30 | $-0.81 | $-0.92 |
| 2023-05-04 | 2023-03-31 | $-0.96 | $-0.80 |
| 2023-03-08 | 2022-12-31 | $-0.98 | $-0.99 |
| 2022-11-09 | 2022-09-30 | $-1.05 | $-1.02 |
| 2022-08-04 | 2022-06-30 | $-1.05 | $-0.84 |
| 2022-05-05 | 2022-03-31 | $-1.39 | $-1.17 |
| 2022-03-09 | 2021-12-31 | $-0.61 | $-0.92 |
| 2021-11-15 | 2021-09-30 | $-1.63 | $-1.55 |
| 2021-08-05 | 2021-06-30 | $-0.41 | $-1.45 |
| 2021-05-06 | 2021-03-31 | $-0.67 | $-1.68 |
| 2021-03-09 | 2020-12-31 | $-0.57 | $-1.43 |
| 2020-11-12 | 2020-09-30 | $-0.99 | $-0.86 |
| 2020-08-06 | 2020-06-30 | $-0.88 | $-0.93 |
| 2020-05-07 | 2020-03-31 | $-0.81 | $-0.86 |
| 2020-03-12 | 2019-12-31 | $-0.85 | $-0.79 |
| 2019-11-06 | 2019-09-30 | $-0.52 | $-0.84 |
| 2019-08-28 | 2019-06-30 | $-0.46 | $-2.29 |